Thomas A Mavrakanas

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

Kidney360

Clinical journal of the American Society of Nephrology : CJASN

Diabetes, obesity & metabolism

Platelets

University Hospital of Geneva

Aristotle University of Thessaloniki School of Medicine (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital of Geneva Aug 01 2017

Switzerland

Staff physician :: Medicine

Harvard Medical School Jul 01 2016

United States

Research Fellow :: Brigham & Women's Hospital, Renal Division

McGill University Health Centre Jul 01 2014 - Jun 30 2016

Canada

Clinical and Research Fellow :: Division of Nephrology

Geneva University Hospitals Oct 01 2009 - Jun 30 2014

Switzerland

Resident until May 2012, then Staff physician :: Division of General Internal Medicine

AHEPA University General Hospital of Thessaloniki

Greece

Resident

Centre Hospitalier d'Alès May 01 2006

France

Resident :: Internal Medicine & Endocrinology

Centre Hospitalier Béziers Nov 01 2005 - Apr 30 2006

France

Resident

Education History

Aristotle University of Thessaloniki School of Medicine

Greece

MSC

Publications

Pedro Marques, Thomas A Mavrakanas, Julian Guida, Tara Gédéon, Anahita Emami, Abdulkhaliq Alaamiri, Daniel Ho, Elite Possik, Guang Zhang, Michael A Tsoukas, Abhinav Sharma
Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: Proof-of-concept results from the DECIDE-CV clinical programme. Diabetes, obesity & metabolism 26 (8) (2024)
Pedro Marques, Thomas A Mavrakanas, Julian Guida, Tara Gédéon, Anahita Emami, Abdulkhaliq Alaamiri, Daniel Ho, Elite Possik, Guang Zhang, Michael A Tsoukas, Abhinav Sharma
Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: Proof-of-concept results from the DECIDE-CV clinical programme. Diabetes, obesity & metabolism (2024)
Thomas A Mavrakanas, David M Charytan
Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation. Kidney360 3 (10) (2022)
Thomas A Mavrakanas, David M Charytan
Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation. Kidney360 3 (10) (2022)
Thomas A Mavrakanas, David M Charytan
Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation. Kidney360 3 (10) (2022)
Amir Razaghizad, Emily Oulousian, Varinder Kaur Randhawa, Joao Pedro Ferreira, James M Brophy, Stephen J Greene, Julian Guida, G Michael Felker, Marat Fudim, Michael Tsoukas, Tricia M Peters, Thomas A Mavrakanas, Nadia Giannetti, Justin A Ezekowitz, Abhinav Sharma
Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of the American Heart Association 11 (10) (2022)
Thomas A Mavrakanas, David M Charytan
Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation. Kidney360 3 (10) (2022)
Thomas A Mavrakanas
Treatment Options for Venous Thromboembolism in Patients Receiving Dialysis. Clinical journal of the American Society of Nephrology : CJASN 17 (5) (2022)
Thomas A Mavrakanas, Omer Kamal, David M Charytan
Prasugrel and Ticagrelor in Patients with Drug-Eluting Stents and Kidney Failure. Clinical journal of the American Society of Nephrology : CJASN 16 (5) (2021)
Thomas A Mavrakanas
Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: COMMENTARY. Kidney360 2 (9) (2021)
Thomas A Mavrakanas, Katherine Garlo, David M Charytan
Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation. Clinical journal of the American Society of Nephrology : CJASN 15 (8) (2020)
Thomas A Mavrakanas, Yiannis S Chatzizisis, Karim Gariani, Dean J Kereiakes, Giuseppe Gargiulo, Gérard Helft, Martine Gilard, Fausto Feres, Ricardo A Costa, Marie-Claude Morice, Jean-Louis Georges, Marco Valgimigli, Deepak L Bhatt, Laura Mauri, David M Charytan
Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis. Clinical journal of the American Society of Nephrology : CJASN 14 (6) (2019)
Thomas A Mavrakanas, Aisha Khattak, Karandeep Singh, David M Charytan
Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD. BMC nephrology 19 (1) (2018)
Thomas A Mavrakanas, Ahsan Alam, Jean-Luc Reny, Andreas Greinacher
Platelet reactivity in stable cardiovascular patients with chronic kidney disease. Platelets 29 (5) (2017)
Thomas A Mavrakanas, Marie-Andrée Fournier, Sarah Clairoux, Jacques-Alexandre Amiel, Marie-Eve Tremblay, Donald C Vinh, Christian Coursol, Daniel J G Thirion, Marcelo Cantarovich
Neutropenia in kidney and liver transplant recipients: Risk factors and outcomes. Clinical transplantation 31 (10) (2017)

Thomas A Mavrakanas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas A Mavrakanas